NFKB1 and acute pancreatitis: Current research on severe acute pancreatitis-related intestinal damage has demonstrated that sitagliptin is capable to reduce the ROS level and alleviate intestinal epithelial cell inflammation, as well as inhibit the NFκB pathway after the activation of Nrf2 [47].